The pilot study of role of electrical cardiometry in non‑invasive assessment of hemodynamic parameters in patients with pulmonary arterial hypertension (RCD code: II‑1A.1)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2017, Vol 3, Issue 2
Abstract
Background: Electrical cardiometry (EC) technique could estimate cardiac output (CO), cardiac index (CI) and other parameters related to cardiac contractility and fluid status by measuring the thoracic electrical bioimpedance. We hypothesized that EC could assess right ventricle (RV) hemodynamic function in patients diagnosed with pulmonary arterial hypertension (PAH). Results: In our pilot study, enrolling 23 PAH patients, we observed a significant correlation (r = 0.71; p <0.001) between thermodilution CO measurement results (4.59 ±1.05 l/min) and CO results obtained by EC (4.86 ±1.20 l/min) and between systemic vascular resistance calculated by EC monitor and obtained during right heart catheterization (RHC) (r = 0.68; p = 0.002). Furthermore, EC parameter index of contractility (ICON) sig‑ nificantly correlated with tricuspid annular plane systolic excursion assessed by echocardiography (r = 0.57; p = 0.01). Conclusions: RHC cannot be replaced in obtaining accurate results of CO, however EC technique provides feasible insight into RV function at the bedside or outpatient care. JRCD 2017; 3 (2): 44–49
Authors and Affiliations
Remigiusz Kazimierczyk, Małgorzata Jasiewicz, Marta Marcinkiewicz‑Siemion, Anna Lisowska, Piotr Błaszczak, Bożena Sobkowicz, Włodzimierz J. Musiał, Ryszard Grzywna, Karol Kamiński
Keywords
Related Articles
- EP ID EP248064
- DOI 10.20418/jrcd.vol3no2.270
- Views 84
- Downloads 0
Isolated left ventricular noncompaction in an asymptomatic althlete (RCD code: III-5A.1.0)
Left ventricular noncompaction (LVNC) is a rare form of cardiomyopathy due to abnormal morphogenesis of the endocardium and myocardium that occurs in early stages of foetal life. Given the increased risk of sudden cardia...
Update on Cardiac Tumors – review (RCD code: VI)
The prevalence of cardiac tumors is 0.021% (1 person in 5000). These data are based on a meta-analysis of pathological studies from the early decades of the twentieth century. It is likely that nowadays the incidence of...
The role of pharmacotherapy in the treatment of chronic thromboembolic pulmonary hypertension (RCD code: II-1A.5)
Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease caused by chronic obstruction of major pulmonary arteries. The median age of patients at diagnosis of CTEPH is 63 years and both genders are...
Pulmonary hypertension inadequate to the clinical condition or hypoxemia disproportionate to the PH severity? (RCD code: II-1B.2)
We present four cases of patients with a history of a pulmonary hypertension (PH), who had a component of lung disease disproportionate to the PH severity. Detailed evaluation revealed pulmonary arterial hypertension (PA...
Patient with multiple myeloma and suspected cardiac amyloidosis (RCD code: III‑3A.2a)
49 year‑old patient with multiple myeloma diagnosed a year earlier, after a few cycles of chemotherapy was admitted to hospital with heart failure symptoms accompanied by a rapid atrial flutter. Echocardiography revealed...